Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects
Condition(s):Hepatic ImpairmentLast Updated:May 26, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hepatic ImpairmentLast Updated:May 26, 2022Completed
Condition(s):Ebola Virus DiseaseLast Updated:February 26, 2020Withdrawn
Condition(s):Outcomes; Survival RatesLast Updated:May 17, 2019Terminated
Condition(s):Ebola VirusLast Updated:February 2, 2015Withdrawn
Condition(s):Adenovirus InfectionLast Updated:August 13, 2021Completed
Condition(s):SmallpoxLast Updated:November 2, 2023Completed
Condition(s):AdenovirusLast Updated:March 14, 2022No longer available
Condition(s):Double-stranded DNA VirusLast Updated:August 12, 2021Completed
Condition(s):Cytomegalovirus Disease; Kidney Transplant InfectionLast Updated:July 16, 2021Terminated
Condition(s):Cytomegalovirus DiseaseLast Updated:July 16, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.